Curia New York Files for DEA Permission on Controlled Drug Imports
Published Date: 8/11/2025
Notice
Summary
Curia New York Inc wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs that are carefully regulated. If approved, it could impact businesses and researchers who rely on these substances, with timing and money details to watch for in the official info.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Importer Registration Application Filed
Curia New York Inc has applied to be registered as an importer of certain controlled substances. If their registration is approved, businesses and researchers that rely on those regulated drugs could be affected. The Federal Register notice points readers to supplementary information for which drugs, timing, and any cost details.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in